AIM-LO: Icosapent ethyl (IPE)

You must be logged in to view this media.

Log in or Register


AIM-LO: Icosapent ethyl (IPE)

Broadcast Date
Amelia Yip, MD, MSc, FRCP
Therapeutic Area

Dr. Amelia Yip explores the role of IPE, a non-statin therapy containing highly purified omega-3 fatty acid EPA, for the reduction of triglycerides in patients with ASCVD and notes the updated recommendation in the Canadian Cardiovascular Society's guidelines.

Handout: Icosepent Ethyl (IPE)

Video Transcript